PRILOCAINE HYDROCHLORIDE

PRILOCAINE HYDROCHLORIDE was reported 162 times

PRILOCAINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 XIITH NERVE INJURY 2 0.1250
1 URINE CHLORIDE DECREASED 1 0.0417
2 PNEUMONIA SERRATIA 1 0.0217
3 HAEMATOLOGICAL NEOPLASM 1 0.0145
4 PELVIC BONE INJURY 1 0.0115
5 BURKITT'S LYMPHOMA 1 0.0095
6 EYELID BLEEDING 1 0.0058
7 NECROTISING FASCIITIS 18 0.0051
8 ORAL CONTUSION 1 0.0043
9 PACHYMENINGITIS 1 0.0038
10 CREATININE URINE INCREASED 1 0.0033
11 POST PROCEDURAL CONTUSION 1 0.0030
12 BLOOD OSMOLARITY INCREASED 1 0.0030
13 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
14 TRIGEMINAL NERVE DISORDER 1 0.0029
15 RADIAL NERVE PALSY 1 0.0028
16 MEDIASTINAL MASS 1 0.0026
17 CAROTID BRUIT 1 0.0026
18 REACTION TO COLOURING 1 0.0024
19 TONIC CLONIC MOVEMENTS 3 0.0023
20 SALIVA ALTERED 2 0.0022
21 BLOOD URIC ACID DECREASED 1 0.0021
22 INFUSION SITE ABSCESS 1 0.0020
23 INFUSION SITE CELLULITIS 1 0.0019
24 MACROGLOSSIA 1 0.0018
25 INTERLEUKIN LEVEL INCREASED 1 0.0018
26 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
27 METHAEMOGLOBINAEMIA 4 0.0017
28 DEVICE MAINTENANCE ISSUE 1 0.0017
29 SACRAL PAIN 1 0.0016
30 OESOPHAGITIS ULCERATIVE 1 0.0015
31 CEREBRAL CYST 1 0.0015
32 ARACHNOIDITIS 1 0.0014
33 FACIAL DISCOMFORT 1 0.0014
34 MALIGNANT ASCITES 1 0.0013
35 LIMB ASYMMETRY 1 0.0013
36 PRODUCT CONFUSION 1 0.0013
37 THERAPEUTIC PRODUCT CROSS-REACTIVITY 1 0.0011
38 ANAESTHETIC COMPLICATION 3 0.0011
39 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
40 HEART TRANSPLANT 1 0.0011
41 BIOPSY 1 0.0011
42 WRIST SURGERY 1 0.0011
43 CROSS SENSITIVITY REACTION 1 0.0010
44 BLADDER DYSFUNCTION 1 0.0010
45 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
46 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
47 IRON OVERLOAD 1 0.0009
48 INFUSION SITE MASS 1 0.0009
49 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
50 PROCALCITONIN INCREASED 1 0.0009
51 ESCHERICHIA TEST POSITIVE 1 0.0008
52 INFUSION SITE WARMTH 1 0.0008
53 BLOOD UREA DECREASED 1 0.0008
54 BLADDER DISCOMFORT 1 0.0008
55 BLOOD BILIRUBIN ABNORMAL 1 0.0008
56 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
57 RHONCHI 1 0.0007
58 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
59 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
60 OEDEMA MOUTH 2 0.0006
61 SPINAL CORD DISORDER 1 0.0006
62 TROPONIN I INCREASED 1 0.0006
63 SKIN WOUND 1 0.0006
64 SPONDYLOLISTHESIS 1 0.0006
65 MECHANICAL VENTILATION 1 0.0005
66 CONVERSION DISORDER 1 0.0005
67 INFUSION SITE SWELLING 3 0.0005
68 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
69 INFUSION SITE BRUISING 1 0.0005
70 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
71 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
72 MENOPAUSE 1 0.0004
73 ANGIONEUROTIC OEDEMA 1 0.0004
74 PLEURITIC PAIN 1 0.0004
75 NECK MASS 1 0.0004
76 HAEMATOLOGICAL MALIGNANCY 1 0.0004
77 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
78 PARAESTHESIA ORAL 5 0.0003
79 PULMONARY PAIN 1 0.0003
80 CARDIOTOXICITY 3 0.0003
81 CREPITATIONS 1 0.0003
82 METABOLIC ENCEPHALOPATHY 1 0.0003
83 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
84 DYSAESTHESIA 1 0.0003
85 INFUSION SITE HAEMORRHAGE 1 0.0003
86 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
87 TYPE I HYPERSENSITIVITY 1 0.0003
88 FIBRIN D DIMER INCREASED 1 0.0003
89 BONE LESION 1 0.0003
90 THROMBOCYTOSIS 1 0.0003
91 PRODUCT STORAGE ISSUE 1 0.0003
92 RHINOVIRUS INFECTION 1 0.0003
93 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
94 OBSTRUCTION 1 0.0003
95 PERIPHERAL VENOUS DISEASE 1 0.0002
96 INFUSION SITE ERYTHEMA 2 0.0002
97 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
98 TUMOUR LYSIS SYNDROME 2 0.0002
99 IMMUNE THROMBOCYTOPENIA 1 0.0002
100 GRAND MAL CONVULSION 2 0.0002
101 CARDIAC TAMPONADE 1 0.0002
102 DIABETIC NEUROPATHY 1 0.0002
103 HYPOAESTHESIA ORAL 3 0.0002
104 COMPRESSION FRACTURE 1 0.0002
105 HEREDITARY ANGIOEDEMA 2 0.0002
106 BEHAVIOUR DISORDER 1 0.0002
107 SKIN LACERATION 2 0.0002
108 GASTRIC ULCER HAEMORRHAGE 1 0.0002
109 NERVE INJURY 2 0.0002
110 EYE INFECTION 2 0.0002
111 BLOOD URIC ACID INCREASED 1 0.0002
112 DECREASED INTEREST 1 0.0002
113 BACTERAEMIA 2 0.0002
114 PLEURISY 1 0.0002
115 INFUSION SITE PAIN 2 0.0002
116 BRONCHIECTASIS 1 0.0001
117 SINUS CONGESTION 2 0.0001
118 WRONG PRODUCT ADMINISTERED 1 0.0001
119 DERMATITIS BULLOUS 1 0.0001
120 ORAL DISORDER 1 0.0001
121 ARTHROPOD BITE 1 0.0001
122 FEELING DRUNK 1 0.0001
123 SNEEZING 3 0.0001
124 ACIDOSIS 1 0.0001
125 HYPOALBUMINAEMIA 1 0.0001
126 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
127 DRUG SCREEN POSITIVE 1 0.0001
128 RESPIRATORY TRACT CONGESTION 2 0.0001
129 ESCHERICHIA INFECTION 1 0.0001
130 AGEUSIA 3 0.0001
131 BLOOD MAGNESIUM DECREASED 1 0.0001
132 CARDIAC MURMUR 1 0.0001
133 HAEMARTHROSIS 1 0.0001
134 MYOSITIS 1 0.0001
135 INCREASED TENDENCY TO BRUISE 1 0.0001
136 UROSEPSIS 1 0.0001
137 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
138 PRODUCT DISTRIBUTION ISSUE 1 0.0001
139 SPINAL DISORDER 1 0.0001
140 SPUTUM DISCOLOURED 1 0.0001
141 POST PROCEDURAL COMPLICATION 2 0.0001
142 LIGAMENT SPRAIN 1 0.0001
143 OVARIAN CYST 1 0.0001
144 DRUG LEVEL DECREASED 1 0.0001
145 NEUTROPHIL COUNT INCREASED 1 0.0001
146 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
147 FOLLICULITIS 1 0.0001
148 INCONTINENCE 1 0.0001
149 BREAST CANCER METASTATIC 1 0.0001
150 PHARYNGITIS STREPTOCOCCAL 1 0.0001
151 SWELLING FACE 6 0.0001
152 TOOTH FRACTURE 1 0.0001
153 GLOSSODYNIA 2 0.0001
154 SKIN INFECTION 1 0.0001
155 DERMATITIS CONTACT 1 0.0001
156 SCAB 1 0.0001
157 MYOCLONUS 1 0.0001
158 PRODUCTIVE COUGH 4 0.0001
159 WRIST FRACTURE 1 0.0001
160 SMALL INTESTINAL OBSTRUCTION 1 0.0001
161 GENERALISED OEDEMA 1 0.0001
162 BRAIN OEDEMA 1 0.0001
163 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
164 RESPIRATORY TRACT INFECTION 2 0.0001
165 PLATELET COUNT INCREASED 1 0.0001
166 MUCOSAL INFLAMMATION 2 0.0001
167 ORAL CANDIDIASIS 1 0.0001
168 PULMONARY CONGESTION 1 0.0001
169 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
170 EAR INFECTION 2 0.0001
171 APHONIA 1 0.0001
172 SEASONAL ALLERGY 1 0.0001
173 HEPATOCELLULAR INJURY 1 0.0001
174 DIALYSIS 1 0.0001
175 ANGIOEDEMA 3 0.0001
176 INSURANCE ISSUE 1 0.0001
177 DEVICE RELATED INFECTION 1 0.0001
178 BRAIN FOG 1 0.0001
179 CYSTITIS 2 0.0001
180 ABSCESS 1 0.0001
181 MUSCLE TIGHTNESS 1 0.0001
182 METASTASES TO BONE 1 0.0001
183 VENTRICULAR TACHYCARDIA 1 0.0001
184 SYNCOPE 6 0.0001
185 BLOOD UREA INCREASED 1 0.0001
186 CIRCULATORY COLLAPSE 1 0.0001
187 BURNING SENSATION 4 0.0001
188 BRADYCARDIA 3 0.0001
189 GOUT 1 0.0001
190 GASTROENTERITIS VIRAL 1 0.0001
191 OSTEOMYELITIS 1 0.0001
192 RESPIRATORY FAILURE 4 0.0001
193 CONJUNCTIVITIS 1 0.0001
194 SWELLING 5 0.0001
195 PHOTOPHOBIA 1 0.0001
196 GASTRIC ULCER 1 0.0001
197 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
198 CONTUSION 5 0.0001
199 PRESCRIBED OVERDOSE 1 0.0001
200 ORAL HERPES 1 0.0001
201 PRODUCT PHYSICAL ISSUE 1 0.0000
202 BODY TEMPERATURE INCREASED 1 0.0000
203 DERMATITIS 1 0.0000
204 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
205 SEPTIC SHOCK 2 0.0000
206 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
207 TOOTH DISORDER 1 0.0000
208 NO ADVERSE EVENT 8 0.0000
209 PRODUCT AVAILABILITY ISSUE 1 0.0000
210 PERICARDIAL EFFUSION 1 0.0000
211 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
212 FIBROMYALGIA 1 0.0000
213 ENCEPHALOPATHY 1 0.0000
214 OSTEONECROSIS OF JAW 1 0.0000
215 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
216 EPISTAXIS 3 0.0000
217 SINUSITIS 4 0.0000
218 HAEMATOMA 1 0.0000
219 DIPLOPIA 1 0.0000
220 FREQUENT BOWEL MOVEMENTS 1 0.0000
221 PALLOR 1 0.0000
222 PROCEDURAL PAIN 1 0.0000
223 HAEMOPTYSIS 1 0.0000
224 NECK PAIN 2 0.0000
225 DEMENTIA 1 0.0000
226 PAIN IN JAW 1 0.0000
227 ANGINA PECTORIS 1 0.0000
228 ACUTE MYOCARDIAL INFARCTION 1 0.0000
229 BLOOD POTASSIUM DECREASED 1 0.0000
230 HEAD INJURY 1 0.0000
231 HEART RATE INCREASED 3 0.0000
232 HEART RATE DECREASED 1 0.0000
233 CEREBRAL HAEMORRHAGE 1 0.0000
234 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
235 C-REACTIVE PROTEIN INCREASED 1 0.0000
236 DYSURIA 1 0.0000
237 INJECTION SITE MASS 1 0.0000
238 DYSGEUSIA 2 0.0000
239 DYSPNOEA EXERTIONAL 1 0.0000
240 BLOOD PRESSURE INCREASED 4 0.0000
241 SEIZURE 3 0.0000
242 HYPOTENSION 5 0.0000
243 THROMBOSIS 2 0.0000
244 OEDEMA PERIPHERAL 3 0.0000
245 LUNG NEOPLASM MALIGNANT 1 0.0000
246 POLLAKIURIA 1 0.0000
247 CARDIO-RESPIRATORY ARREST 1 0.0000
248 RENAL FAILURE ACUTE 1 0.0000
249 URINARY TRACT INFECTION 4 0.0000
250 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
251 THROAT IRRITATION 1 0.0000
252 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
253 DYSPHAGIA 2 0.0000
254 NEUROPATHY PERIPHERAL 2 0.0000
255 COMA 1 0.0000
256 MIGRAINE 2 0.0000
257 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
258 INTERSTITIAL LUNG DISEASE 1 0.0000
259 ATRIAL FIBRILLATION 2 0.0000
260 LUNG DISORDER 1 0.0000
261 CELLULITIS 1 0.0000
262 CHEST DISCOMFORT 2 0.0000
263 INFLAMMATION 1 0.0000
264 NERVOUSNESS 1 0.0000
265 PARAESTHESIA 3 0.0000
266 OVERDOSE 4 0.0000
267 OEDEMA 1 0.0000
268 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
269 ANAPHYLACTIC REACTION 1 0.0000
270 MUSCULAR WEAKNESS 2 0.0000
271 CONVULSION 1 0.0000
272 DRUG INEFFECTIVE 23 0.0000
273 HERPES ZOSTER 1 0.0000
274 PAIN IN EXTREMITY 5 0.0000
275 WHEEZING 1 0.0000
276 STOMATITIS 1 0.0000
277 PLEURAL EFFUSION 1 0.0000
278 FEELING HOT 1 0.0000
279 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
280 PRODUCT USE ISSUE 3 0.0000
281 ANAEMIA 3 0.0000
282 RHINORRHOEA 1 0.0000
283 FEBRILE NEUTROPENIA 1 0.0000
284 BLOOD PRESSURE DECREASED 1 0.0000
285 FALL 5 0.0000
286 NEOPLASM MALIGNANT 1 0.0000
287 PYREXIA 5 0.0000
288 INJURY 1 0.0000
289 DYSPNOEA 8 0.0000
290 MOBILITY DECREASED 1 0.0000
291 PRODUCT DOSE OMISSION ISSUE 4 0.0000
292 WEIGHT INCREASED 3 0.0000
293 HYPOAESTHESIA 2 0.0000
294 HOT FLUSH 1 0.0000
295 CHRONIC KIDNEY DISEASE 1 0.0000
296 PERIPHERAL SWELLING 2 0.0000
297 DECREASED APPETITE 3 0.0000
298 ABDOMINAL PAIN 3 0.0000
299 ARTHRITIS 1 0.0000
300 DRUG INTERACTION 2 0.0000
301 CARDIAC FAILURE 1 0.0000
302 CARDIAC FAILURE CONGESTIVE 1 0.0000
303 BALANCE DISORDER 1 0.0000
304 MALAISE 5 0.0000
305 COVID-19 2 0.0000
306 PAIN 7 0.0000
307 TACHYCARDIA 1 0.0000
308 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
309 GASTROINTESTINAL DISORDER 1 0.0000
310 ADVERSE DRUG REACTION 1 0.0000
311 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
312 NASOPHARYNGITIS 2 0.0000
313 OROPHARYNGEAL PAIN 1 0.0000
314 CHEST PAIN 2 0.0000
315 HYPERSENSITIVITY 2 0.0000
316 WEIGHT DECREASED 3 0.0000
317 COUGH 3 0.0000
318 CARDIAC DISORDER 1 0.0000
319 ASTHENIA 4 0.0000
320 PULMONARY EMBOLISM 1 0.0000
321 DRUG INTOLERANCE 1 0.0000
322 DYSPEPSIA 1 0.0000
323 FLUSHING 1 0.0000
324 ERYTHEMA 2 0.0000
325 ILLNESS 1 0.0000
326 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
327 ABDOMINAL DISTENSION 1 0.0000
328 HAEMORRHAGE 1 0.0000
329 HYPERTENSION 2 0.0000
330 INFLUENZA 1 0.0000
331 ASTHMA 1 0.0000
332 DEPRESSION 2 0.0000
333 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
334 BACK PAIN 2 0.0000
335 PALPITATIONS 1 0.0000
336 CHILLS 1 0.0000
337 DISEASE PROGRESSION 1 0.0000
338 FEELING ABNORMAL 2 0.0000
339 JOINT SWELLING 1 0.0000
340 VISUAL IMPAIRMENT 1 0.0000
341 HEADACHE 5 0.0000
342 LOSS OF CONSCIOUSNESS 1 0.0000
343 PSORIASIS 1 0.0000
344 NEUTROPENIA 1 0.0000
345 VISION BLURRED 1 0.0000
346 MEMORY IMPAIRMENT 1 0.0000
347 ARTHRALGIA 3 0.0000
348 INFECTION 1 0.0000
349 HOSPITALISATION 1 0.0000
350 FATIGUE 5 0.0000
351 URTICARIA 1 0.0000
352 ABDOMINAL DISCOMFORT 1 0.0000
353 TOXICITY TO VARIOUS AGENTS 1 0.0000
354 MYOCARDIAL INFARCTION 1 0.0000
355 MUSCLE SPASMS 1 0.0000
356 GAIT DISTURBANCE 1 0.0000
357 SOMNOLENCE 1 0.0000
358 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
359 ABDOMINAL PAIN UPPER 1 0.0000
360 RASH 2 0.0000
361 OFF LABEL USE 4 0.0000
362 INCORRECT DOSE ADMINISTERED 1 0.0000
363 DIZZINESS 2 0.0000
364 NAUSEA 3 0.0000
365 INSOMNIA 1 0.0000
366 ANXIETY 1 0.0000
367 CONDITION AGGRAVATED 1 0.0000
368 INJECTION SITE PAIN 1 0.0000
369 PNEUMONIA 1 0.0000
370 PRURITUS 1 0.0000
371 VOMITING 1 0.0000
372 DIARRHOEA 1 0.0000
373 DEATH 1 0.0000